Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study-论文-万方医学网

首页> > Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study

Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study

导出原文传递

翻译打印收藏纠错

第一作者： Liu, Ying L.

作者： Liu, Ying L. ^[1] ; Zhou, Qin C. ^[2] ; Iasonos, Alexia ^[3] ; Chi, Dennis S. ; Zivanovic, Oliver ; Sonoda, Yukio ; Gardner, Ginger ; Broach, Vance ; O'Cearbhaill, Roisin ; Konner, Jason A. ; Grisham, Rachel ; Aghajanian, Carol A. ; Abu-Rustum, Nadeem R. ; Tew, William ; Long Roche, Kara

作者单位： Med,Mem Sloan Kettering Canc Ctr ^[1] Epidemiol & Biostat,Mem Sloan Kettering Canc Ctr ^[2] Surg,Mem Sloan Kettering Canc Ctr ^[3]

关键词 ovarian cancer INTERVAL DEBULKING SURGERY GYNECOLOGIC ONCOLOGY CYTOREDUCTION PERITONEAL IMPACT

发布时间 2022-05-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study

相似文献

同项目论文

相关期刊

检索历史 清除

Pre-operative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer: what is the optimal number? A Memorial Sloan Kettering Cancer Center Team Ovary study

相似文献

同项目论文

相关期刊

检索历史清除